Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

YH-1885 for one week significantly inhibits intragastric acidity in humans

Nov. 4, 2002

Effects of Enteryx on LES function in GERD patients

Nov. 4, 2002

New class of CpG oligonucleotides with promise for HCV infection

Oct. 31, 2002

Potent and gut-selective Ca2+ channel antagonist with potential in IBS

Oct. 30, 2002

Jerini initiates phase I trial of icatibant for decompensated liver cirrhosis

Oct. 29, 2002

Patient randomization completed in phase II liver fibrosis trial of Actimmune

Oct. 28, 2002

New DHFR inhibitors in early development at Melacure

Oct. 25, 2002

French researchers describe 5-HT4 ligands with potential in GI and other disorders

Oct. 25, 2002

CDP-571 as a safe and effective option for Crohn's disease

Oct. 24, 2002

Potential use of theophylline in the management of functional chest pain

Oct. 24, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...